[Weekly IPO] HL Genomics Subscription and Payment Underway… Remedi Enters KOSDAQ

In the third week of July 2026 (July 13-17), a total of 2 preliminary listing examination requests were received in the domestic IPO market, while 1 company proceeded with public offering subscription and payment, and 1 company was newly listed on the KOSDAQ.

Listing Requests

• iM SPAC 1: Filed a preliminary examination on July 13 for listing on the KOSDAQ. The lead underwriter is iM Securities.

• Everon: A comprehensive electric vehicle charging infrastructure service company that covers EV charger manufacturing, installation, operation, and AI-based charging control solutions. It submitted a preliminary examination claim form on July 13 with the goal of listing on the KOSDAQ. The lead underwriter is Mirae Asset Securities Co., Ltd.

Public Offering in Progress (Subscription and Payment)

• HL Genomics: Completed the subscription and payment process at a public offering price of 21,500 won. It is pushing for a KOSDAQ listing, with KB Securities and IBK Investment & Securities acting as joint lead underwriters.

Listing

• Remedi: A specialized company that develops portable medical and dental X-ray devices and radiation therapy devices for cancer treatment based on highly focused X-ray generation technology. It successfully made its new entry into the KOSDAQ market under the lead underwriting of KB Securities Co., Ltd.

Next Week's Schedule

• Ingenia Therapeutics: A Korean-American biotech company developing new drugs for intractable vascular diseases such as diabetic macular edema and wet macular degeneration based on a protein engineering technology platform (Tie2 activation).. It is scheduled to proceed with a public offering subscription for listing on the KOSDAQ. The lead underwriter is Samsung Securities.

• HL Genomics: A genome analysis specialized company that provides early diagnosis of cancer and rare diseases, as well as customized healthcare solutions, utilizing next-generation sequencing (NGS)-based genetic testing technology. It is scheduled for a new listing on the KOSDAQ market. The lead underwriters are KB Securities and IBK Investment & Securities.